regarding avghd only and what we know. Rules were different for two separate bio companies trialing same disease.
Goal posts were moved by the FDA.
FDA discounted, MSB and experts reasons for doing a single arm treatment for children under 12.
FDA weighted heavily on the failed trial and the single arm treatment, and ignored positive read out for children under 12, for both old and recent trial.
MSB Trading 2021 - paradigm shift, page-837
-
- There are more pages in this discussion • 9,374 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |